|
|||||
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
REGN | Powchik Peter | SVP Clinical Development & Reg | Dec 16 | Option Exercise | 52.03 | 1,921 | 99,950 | 17,742 | Dec 18 04:27 PM |
REGN | Powchik Peter | SVP Clinical Development & Reg | Aug 13 | Option Exercise | 117.33 | 60,361 | 7,082,070 | 46,299 | Aug 17 04:01 PM |
REGN | Powchik Peter | SVP Clinical Development & Reg | Aug 14 | Sale | 573.38 | 23,485 | 13,465,866 | 15,821 | Aug 17 04:01 PM |
REGN | Powchik Peter | SVP Clinical Development & Reg | Dec 31 | Option Exercise | 52.03 | 25,000 | 1,300,750 | 35,711 | Jan 05 04:28 PM |
REGN | Powchik Peter | SVP Clinical Development & Reg | Jan 02 | Sale | 414.08 | 10,822 | 4,481,214 | 10,711 | Jan 05 04:28 PM |
REGN | Powchik Peter | SVP Clinical Development & Reg | Dec 19 | Option Exercise | 30.63 | 3,264 | 99,976 | 10,711 | Dec 22 12:09 PM |
REGN | Powchik Peter | SVP Clinical Development & Reg | Dec 31 | Option Exercise | 30.63 | 48,000 | 1,470,240 | 73,447 | Jan 03 04:10 PM |
REGN | Powchik Peter | SVP Clinical Development & Reg | Jan 02 | Sale | 274.77 | 20,668 | 5,678,965 | 25,447 | Jan 03 04:10 PM |
REGN | Powchik Peter | SVP Clinical Development & Reg | Dec 24 | Option Exercise | 21.25 | 4,705 | 99,981 | 25,447 | Dec 26 01:26 PM |
REGN | Powchik Peter | SVP Clinical Development & Reg | Dec 18 | Option Exercise | 21.25 | 295 | 6,269 | 21,037 | Dec 20 05:54 PM |
REGN | Powchik Peter | SVP Clinical Development & Reg | Dec 18 | Sale | 270.20 | 9,000 | 2,431,800 | 20,742 | Dec 20 05:54 PM |
REGN | Powchik Peter | SVP Clinical Development & Reg | Dec 20 | Sale | 271.09 | 133 | 36,055 | 20,742 | Dec 20 05:54 PM |
REGN | Powchik Peter | SVP Clinical Development & Reg | Dec 16 | Option Exercise | 107.14 | 30,625 | 3,281,056 | 38,503 | Dec 17 04:16 PM |
REGN | Powchik Peter | SVP Clinical Development & Reg | Dec 17 | Sale | 270.00 | 8 | 2,160 | 29,742 | Dec 17 04:16 PM |
REGN | Powchik Peter | SVP Clin Devel & Reg Affairs | Jan 09 | Option Exercise | 17.38 | 5,752 | 99,980 | 20,742 | Jan 10 09:25 AM |
REGN | Powchik Peter | SVP Clin Devel & Reg Affairs | Jan 02 | Option Exercise | 21.25 | 30,000 | 637,500 | 44,990 | Jan 04 10:00 AM |
REGN | Powchik Peter | SVP Clin Devel & Reg Affairs | Jan 03 | Sale | 182.11 | 13,586 | 2,474,091 | 14,990 | Jan 04 10:00 AM |
REGN | Powchik Peter | SVP Clin Devel & Reg Affairs | Dec 18 | Option Exercise | 31.61 | 38,248 | 1,209,090 | 39,446 | Dec 20 04:17 PM |
REGN | Powchik Peter | SVP Clin Devel & Reg Affairs | Dec 19 | Sale | 178.50 | 10,356 | 1,848,536 | 21,613 | Dec 20 04:17 PM |
REGN | Powchik Peter | SVP Clin Devel & Reg Affairs | Dec 20 | Sale | 170.64 | 6,623 | 1,130,164 | 14,990 | Dec 20 04:17 PM |
REGN | Powchik Peter | SVP Clinical Development & Reg | Nov 08 | Sale | 138.62 | 15,144 | 2,099,221 | 14,990 | Nov 09 10:27 AM |
REGN | Powchik Peter | SVP Clinical Development & Reg | Aug 01 | Option Exercise | 17.55 | 14,990 | 263,093 | 30,134 | Aug 02 10:56 AM |
REGN | Powchik Peter | SVP Clinical Development & Reg | Jul 25 | Option Exercise | 16.80 | 15,000 | 252,000 | 30,144 | Jul 27 11:10 AM |
REGN | Powchik Peter | SVP Clinical Development & Reg | Jul 26 | Sale | 130.64 | 7,019 | 916,953 | 15,144 | Jul 27 11:10 AM |
REGN | Powchik Peter | SVP Clinical Development & Reg | Feb 21 | Option Exercise | 18.10 | 109,866 | 1,989,055 | 72,662 | Feb 23 11:46 AM |
REGN | Powchik Peter | SVP Clinical Development & Reg | Feb 22 | Sale | 96.34 | 49,254 | 4,745,316 | 15,144 | Feb 23 11:46 AM |
REGN | Powchik Peter | SVP Clinical Development | Aug 01 | Option Exercise | 15.64 | 15,144 | 236,852 | 15,144 | Aug 02 04:05 PM |
REGN | Powchik Peter | SVP Clinical Development | Jul 25 | Option Exercise | 15.64 | 25,000 | 391,000 | 25,000 | Jul 26 04:17 PM |
REGN | Powchik Peter | SVP Clinical Development | Jul 26 | Sale | 54.89 | 10,977 | 602,491 | 0 | Jul 26 04:17 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite